274
Participants
Start Date
May 1, 2022
Primary Completion Date
December 31, 2027
Study Completion Date
December 31, 2027
Bonjesta
Extended-release tablets contain 20 mg of doxylamine succinate and 20 mg of pyridoxine hydrochloride. Minimum 1 tablet at bedtime. Up to two pills daily (one tablet in the morning and one tablet at bedtime). The treatment duration is 15 days.
Placebo
Sugar pills with no active ingredients. Minimum 1 tablet at bedtime. Up to two pills daily (one tablet in the morning and one tablet at bedtime). The treatment duration is 15 days.
RECRUITING
Unified Women's Clinical Research, Winston-Salem
RECRUITING
Clinovacare Medical Research Center, West Columbia
RECRUITING
Emerald Coast OB/GYN Clinical Research, Panama City
RECRUITING
Vital Pharma Research, Hialeah
RECRUITING
New Horizon Research Center, Miami
RECRUITING
Axon Clinical Research, Mesquite
RECRUITING
Maximos OBGYN, League City
RECRUITING
Advances in Health, Pearland
RECRUITING
Clinical Research Prime, Idaho Falls
RECRUITING
Velvet Clinical Research, Burbank
Lead Sponsor
Collaborators (1)
Premier Research
OTHER
Duchesnay Inc.
INDUSTRY